Member of RFK Jr's new vaccine panel withdraws over conflict of interest
A member of the health secretary Robert F Kennedy Jr's newly overhauled federal vaccine advisory panel withdrew after a conflict of interest review, a spokesperson has told the Guardian.
Dr Michael Ross, who was involved in multiple private healthcare companies, withdrew after review of his financial holdings.
Kennedy unilaterally fired all 17 members of the Centers for Disease Control and Prevention's (CDC) advisory committee on immunization practices (ACIP) in June, arguing they had too many conflicts of interest.
Related: Who are the eight new vaccine advisers appointed by Robert F Kennedy?
Ross was among eight of Kennedy's ideological allies appointed to the committee, after the secretary argued the old members of the committee were subject to too many conflicts of interest.
'Yesterday, Dr Michael Ross decided to withdraw from serving on ACIP during the financial holdings review,' a spokesperson for the Department of Health and Human Services (HHS) said.
'The sacrifice to serve on ACIP varies from member to member, and we appreciate Dr Ross's willingness to go through this rigorous process.'
The spokesperson made the comments after Guardian inquiries about conflict of interest disclosures for new members of ACIP. Although the Trump administration and Kennedy developed a conflict of interest tracker specifically for ACIP members, Kennedy's appointees have not been added.
The HHS spokesperson did not respond to Guardian inquiries about when and where new, written conflict of interest disclosures would be published.
Instead, the spokesperson said the department has, 'comprehensively reviewed all newly appointed ACIP members for conflicts of interests in accordance with federal law, regulations and departmental polices', and that the members were provided 'ethics training prior to discharging their duties'.
The new members of the committee were asked to disclose conflicts of interest before the meeting began on Wednesday. The committee chair Dr Martin Kulldorff and committee member Dr Robert Malone omitted widely reported work in vaccine litigation, and nurse Vicky Pebsworth said she was 'asked to read' a statement disclosed ownership of a healthcare stock but said it was below the government ethics office threshold for reporting.
Ethics review of the new members was also the subject of Senate testimony on Wednesday.
Under questioning by the Democratic senator Patty Murray of Washington, the Trump nominee to head the CDC, Dr Susan Monarez, said she was 'not familiar whether or not the members that are participating in the meeting this week have or have not gone through the ethics review necessary to allow them to participate in those meetings'.
'If it is known that they have not gone through the ethics process and they issue recommendations, would you accept them as valid?' asked Murray.
'If they have not gone through an ethics approval process, they shouldn't be participating in the meetings,' said Monarez.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
7 Reasons You Might Be Experiencing Joint Pain, According to an Expert
Joint pain can make it difficult to carry out basic tasks, from walking up the stairs to opening a jar and even typing. When it comes to the skeletal system, our joints have some of the most important jobs. A joint refers to any place where two or more bones meet — we have hundreds of them around our body, especially in the limbs. These complex junctions allow for movement and flexibility, while also providing stability. Joints are made up of bones, cartilage, ligaments, tendons, nerves and fluid, per the Cleveland Clinic. All of these work together to give our otherwise rigid skeleton a wide range of motion. Different joints allow different types of movement. There are hinge joints, which allow limbs to bend and straighten, such as the elbows, knees, or fingers. Ball and socket joints, like the hips, allow movement in all directions and pivot joints permit our head to rotate. Joint pain can affect one or more of the body's joints and range from mild discomfort to severe pain, limiting mobility. It may be accompanied by stiffness, swelling, and clicking or grinding sensations. The pain can be constant or worsen with movement. There are many causes for joint pain, from normal aging to autoimmune diseases and infections. spoke with Dr. Natalie Azar, NBC News medical contributor and board-certified rheumatologist at NYU Langone Health, about common types of joint pain and what your achy joints may be telling you about your health. First, it's important to distinguish between joint and muscle pain, which are often confused, Azar tells Muscle pain affects one or multiple muscle groups and is more of a deep aching that occurs with movement and gets better with rest. It may follow overexertion during a workout, poor posture, or stress and tension. Joint pain (arthralgia) specifically affects the joints and can worsen with movement or be present at rest. Joint pain may also be associated with inflammation, swelling, stiffness and limited range of motion, Azar notes. 'It's really important for us to narrow down the diagnosis," she adds. In addition to the severity and duration of pain, a doctor will look at your medical history, age, gender and other symptoms to pinpoint the cause. Arthritis is an umbrella term for hundreds of conditions that cause joint pain and inflammation. "The first thing that we do is try to figure out if the arthritis is inflammatory versus non-inflammatory," Azar says. Inflammatory arthritis occurs when the immune system overacts and mistakenly attacks joint tissue. It often starts in the hands or feet. "We're looking for symptoms of swelling associated with the pain," says Azar. Joints may feel stiff, appear red or feel warm. Common causes for inflammatory arthritis include autoimmune diseases, such as rheumatoid arthritis, psoriatic arthritis or lupus, says Azar. In addition to joint pain, these can cause skin rashes, oral ulcers, hair loss and gastrointestinal issues. "If your symptoms involve more than two organ systems, we may start thinking autoimmune," says Azar. Inflammatory arthritis can occur at any age, per the Mayo Clinic. Risk factors include having a family history of arthritis and being female. "Most types of arthritis are more common in women for a variety of reasons, including hormones, muscle mass and the way our skeleton is formed," says Azar. Sometimes, joint pain is a normal part of aging or overuse. Non-inflammatory arthritis is caused by the breakdown of cartilage between the joints. 'The most common type, osteoarthritis, is the wear and tear, degenerative kind of arthritis,' says Azar. It commonly affects weight-bearing joints like the hips and knees, and joints in the spine. 'Most of us develop a degree of arthritis as we get older, for example, pretty much everyone will have back pain at some point,' says Azar. Repetitive movements — during a sport or a job, for example — can also break down joint cartilage, causing pain. Osteoarthritis often occurs after age 55 and is more common in women, per the Cleveland Clinic. It can be accelerated by lifestyle factors, weight and menopause. In severe cases, osteoarthritis can limit mobility, but many people with osteoarthritis can still live an active life, says Azar. Joint pain can also result from injuries, such as fractures, strains and sprains, says Azar. These can cause acute pain or affect the structure of the joint, increasing the risk of arthritis later on. Post-trauma joint pain is often sudden and is often accompanied by swelling, says Azar. It commonly affects the knees, hips, ankles and shoulders. Injuries to the tissues around joints — such as the ligaments, tendons (tendonitis) and fluid-filled sacs cushioning the bones called bursae (bursitis) — can also cause pain. Joint pain may range from mild to severe, but it's usually temporary. "Any joint pain after trauma that lasts beyond a couple of days, you probably want to get checked out," says Azar. Sometimes, joint pain is associated with more widespread, chronic pain. A possible cause is fibromyalgia, a condition that affects the entire musculoskeletal system, causing pain throughout the body and extreme tiredness, per the Cleveland Clinic. It can cause multiple joints to feel sore, tender and sensitive. 'If your joint pain is associated with fatigue and non-restorative sleep, it may be fibromyalgia,' Azar adds. Fibromyalgia can also cause mental symptoms, and it's more common in women. Unlike arthritis, fibromyalgia does not directly damage the joints, and the cause is unknown. Hypermobility, often called "double-jointedness" occurs when a person's joints have a greater range of motion than normal. It can affect one or more joints and may be isolated or a symptom of a connective tissue disorder. Hypermobility can be benign, but many patients have joint pain, says Azar. The extra flexibility can cause joints to overstretch or lose stability. This can result in pain, stiffness or swelling, and joints may make a clicking or popping sound. Activities like stretching can worsen pain. 'Exercise is good, but you've got to do a lot of strength training or work with a physical therapist ... and resist the urge to do the deepest downward dog in yoga,' says Azar. Sometimes, joint pain is caused by bacterial or viral infections, says Azar. Infectious arthritis occurs when an infection in one part of the body spreads through the bloodstream to the joints, where it causes inflammation and pain, per the Mayo Clinic. It's often sudden and severe. Possible causes include staphylococcus aureus, a bacteria that lives on the skin, and Neisseria gonorrhoeae, which causes the sexually transmitted infection gonorrhea, Azar says. Joint pain is also a symptom of Lyme disease. "A tick exposure ... and bull's eye rash (are) clues that a patient may have Lyme," says Azar. Viral infections that can cause joint pain include COVID, hepatitis, rubella, parvovirus B19 and chikungunya. The pain may be accompanied by a fever, chills or fatigue. "A detailed medical history, and travel history, is super important," says Azar, adding that testing is necessary to determine the cause and best treatment. Joint pain may be related to deficiencies in nutrients that support bone health, such as vitamin D and calcium, says Azar. Vitamin D allows the body to absorb the mineral calcium. Together, these help us grow and maintain healthy bones. A deficiency in vitamin D or calcium may not cause symptoms in the early stages. However, over time, not getting enough of these nutrients can affect bone health and cause pain in the joints, Azar notes. These deficiencies can also worsen existing arthritis and increase the risk of fractures. Joint pain isn't always a sign of something serious. However, it may be worth checking out if it interferes with daily activities. 'If you have joint pain that lasts for more than one to two weeks without an obvious explanation, you should see a doctor," says Azar. Treatment will vary depending on the cause. In many cases, joint pain can be managed with over-the-counter pain relievers, physical therapy or corticosteroid injections. Physical therapy can also help improve mobility and strengthen joints. There are also lifestyle habits that may help support healthy joints and reduce pain, says Azar. These include: Eating a nutritious, anti-inflammatory diet Exercising (as much as you can tolerate) Maintaining good posture Maintaining a healthy weight Avoiding smoking Getting enough rest Reducing stress This article was originally published on
Yahoo
37 minutes ago
- Yahoo
Some early-onset cancers are on the rise. Why?
When you buy through links on our articles, Future and its syndication partners may earn a commission. Some early-onset cancers — those that occur in people under age 50 — are on the rise in the United States. This overall increase is due to a rise in 14 different types of cancers in younger people, according to a new analysis. The largest increases have occurred in breast, colorectal, kidney and uterine cancer diagnoses. While the overall incidence of early-onset cancer is still low, these small increases could add up over time. A rise of a few percent per year is "not a huge change in the number of diagnoses, because cancer is still rare at these ages," Miranda Fidler-Benaoudia, a cancer epidemiologist at Alberta Health Services and the University of Calgary, told Live Science. "But it's when it's happening over two, three decades that it really leads to a meaningful increase in that period." The reasons behind these increases are complex and manifold, and many are probably specific to each type of cancer, experts say. To tease out trends in early-onset cancer diagnoses and the myriad reasons behind them, National Cancer Institute epidemiologist Meredith Shiels and colleagues compiled data on cancers diagnosed in 15- to 49-year-olds between 2010 and 2019 in the U.S. In a study published May 8 in the journal Cancer Discovery, the team broke down changes in the rates of different cancers in three age groups: 15 to 29, 30 to 39, and 40 to 49. Breast and uterine cancer rates increased in every early-onset age group, while rates of colorectal and certain kidney cancers increased among 30- to 39-year-olds and 40- to 49-year-olds, the team found. More than 80% of the additional cancers that occurred in 2019 compared with 2010 were one of these four types. Other diagnoses that increased in at least one early-onset cohort included melanoma, cervical cancer and stomach cancer, though incidences of these cancers remained low overall. Many factors could contribute to these observed increases. Research suggests that obesity is a risk factor for colorectal, kidney and uterine cancers, all of which are rising in younger people. Globally, the percentage of adults who are overweight or obese has increased significantly since 1990. Although most studies linking cancer and obesity were conducted in older adults, it's possible that higher rates of obesity in younger people could also increase the rates of early-onset cancer, the researchers wrote. One 2024 study suggests that more than half of uterine cancers diagnosed in 2019 might be linked to obesity. Changes in reproductive patterns over the years could also be contributing to the increased incidence of early-onset breast cancers, Fidler-Benaoudia said. Girls are getting their periods earlier, and women are having fewer children, and having them later in life, than they did a few generations ago. Being younger at first menstruation, giving birth fewer times, and giving birth for the first time later in life have all been linked to a higher risk of developing certain types of early-onset breast cancer, the researchers wrote. Other research suggests that using oral contraceptives (birth control pills) might also slightly elevate the risk of early-onset breast cancer, though it may also protect against ovarian and endometrial cancers. Earlier detection of cancers in people with genetic risk factors may also play a role. For instance, those with certain BRCA gene variants have a higher risk of breast, ovarian or prostate cancer, while those with Lynch syndrome face an increased risk of myriad cancers, including colon cancer, stomach cancer and brain cancer. I think that we need large studies that follow individuals over the life course, including at younger ages, to be able to identify risk factors for early-onset cancers. Meredith Shiels Newer screening guidelines recommend people with these genes start screening for cancer earlier than those with an average risk of the disease. Even a small increase in the number of early-onset cancers detected via these new recommendations could trigger an uptick in diagnoses. Screening for other, unrelated issues could also help identify certain cancers earlier. For example, changes in imaging procedures for MRIs and CT scans mean that health care professionals are catching more instances of renal cell carcinoma, a type of kidney cancer, during other tests. This incidental detection has led to an increase in kidney cancer diagnoses in almost all age groups, the researchers wrote. People's prenatal or early-life exposures to certain compounds may also fuel specific early-onset cancers. Researchers reported in April in the journal Nature that childhood exposure to a chemical called colibactin, which is produced by certain E. coli strains in the colon, causes DNA mutations observed more frequently in early-onset colorectal cancers. Showing that an exposure directly causes a certain type of early-onset cancer — or even pinpointing which types of exposures might pose a risk — is no easy feat. "I think that we need large studies that follow individuals over the life course, including at younger ages, to be able to identify risk factors for early-onset cancers," Shiels told Live Science in an email. RELATED STORIES —Gut bacteria linked to colorectal cancer in young people —BRCA only explains a fraction of breast cancers — genes tied to metabolism may also up risk —Black patients may need breast cancer screenings earlier than what many guidelines recommend Even with these sorts of extended studies, though, it can be challenging to pin down the exact causes of early-onset cancer. "The issue with cancer at young ages is, whilst it's increasing, it's still relatively rare [compared] to those older age groups," Fidler-Benaoudia said. "To have enough people develop cancer to then identify risk factors in this prospective way is incredibly challenging, because you need huge, huge numbers." While it's impossible to eliminate your individual risk of getting cancer, there are some things that reduce the overall risk at the population level. For instance, wearing sun protection and getting vaccinated against human papillomavirus (HPV) can help protect against certain cancers, Fidler-Benaoudia said. Similarly, limiting alcohol and smoking can reduce the odds of a person developing cancer at any point in their life, not just before age 50, Tomotaka Ugai, a cancer epidemiologist at the Harvard T.H. Chan School of Public Health and Brigham and Women's Hospital, told Live Science.
Yahoo
37 minutes ago
- Yahoo
Dr. Loh: In the crosshairs — American healthcare leadership
In these unpredictable times in healthcare, it seems that an overview of where we are, how we got here, and where we go from here, might be worthwhile before going back to dealing with the implications of some of the shortsighted policies instigated by whim and ignorance by people placed into positions of great power based on fealty rather than competence. Unfortunately, it is the public and their progeny that have to deal with the consequences. If you do not agree with these statements, remember this is an opinion article. Feel free to express yours in this forum. An informed dialogue is good for a democracy. Childish behavior, bullying, and yelling, are not. America has traditionally led in the fields of biomedical research and technology, as well as in the basic sciences that underpin those advances. All of humanity has potentially benefited from our medical research. Yet our outcomes do not track with the quality of our medical science, e.g., maternal mortality, lifespan, etc. Some of this is explainable by lifestyle choices. But another contributor is the well-documented problem that in the U.S., getting access to that fantastic care is inequitable and affected by one's income, social status, and zip code. This is why despite having the best biomedical science, we have third-world outcome data for some of the actual care being delivered. Having profit-driven middle-man insurance and pharmaceutical benefit manager companies placed between a human being that needs care, and a trained clinician capable of doing that care only exacerbates the disparity between what is possible and what is probable. Some of these factors have been called the social determinants of health, and are quite unpopular now in hallways of American power, so it is quite unlikely that there will be any meaningful movement towards correcting these issues. It's easier to blame an immigrant, legal or otherwise, or a single mother, minority or otherwise, trying to care for her family, than to look in the mirror to see where the real problems are. Those of you who have followed my columns for decades know that I recently cut back from clinical practice after 45 years, but that I have been a clinical researcher for over 50 years. Over these years, I've seen healthcare make many changes, driven by financial pressures on the federal government to deliver affordable healthcare, and to not undermine the for-profit insurance industry. Increased taxes (by many names) and decreased benefits (by many health plans) have been the 'adjustments' required to try and keep an unsustainable healthcare system functional. They did this by kicking the financial can down the road so that the next Congress and next administration would have to deal with it. This has, by the way, been going on since around WWI (one!) from the time of Woodrow Wilson. The current administration, through DOGE, and its selection of individuals uniquely and unequivocally unfit for their healthcare positions, has embarked on a wholesale dismemberment of our healthcare system. This is not to make it more efficient as they claim, but to cut the biggest costs (healthcare) out of our federal budget so that the uber-wealthy can keep their tax cuts due to expire soon. And yet the proposed Big Beautiful Bill will jack our national debt to even more obscene levels, to be borne by our children and children's children. We are the only allegedly civilized country that regularly drives its citizens into bankruptcy because of the cost of getting healthcare. And our Congressional and Senate leadership have been complicit in this. Indeed, the proposed cuts to Medicaid are likely, if implemented, to break the financial back of many smaller rural American hospitals that are barely getting by now and consequently exacerbating the difficulties in getting access to care. Through coarse Draconian budgetary slashes, DOGE and Congress have laid waste to the NIH, academic and myriad basic science labs in the U.S. as well as those sponsored by partner labs around the world. As a result, we are not only losing the science that has made American biomedical research the envy of the world, we are losing the next generation of scientists who have lost their funding. Some of the best and brightest biomedical minds are being poached by academic institutions, basic science labs and pharmaceutical labs from around the world. These scientists are vulnerable since they want to continue to do the work to which they have dedicated their lives and have been trained to do. That work is what drives progress in understanding and treating the chronic diseases that MAHA purports to support, but clearly does not understand how it it done. Many of the new investigational products I am being offered and am seeing at my research site, are the products of basic science work increasingly coming from sources outside the U.S. More clinical trials are now being done outside the U.S. than within. In the past, these developments would have been welcome as evidence of the collaboration clinical scientists have enjoyed for decades. Much of it because many of their scientists were trained here, developed their post-graduate careers here, stayed and have been immensely productive. Some inevitably return home to build labs and continue to do the science there and train new colleagues. This is the nature of America's soft power, the intellectual and moral inculcation of the best minds into what truly made America great. Now the shift is more ominous because young foreign investigators are feeling targeted and being made to feel unwelcome. Science does not care about your gender, race, ethnicity, politics, or religious preference, if any. It is the pursuit of new knowledge, ideally for the benefit of humankind. How humans use that knowledge is another topic, and is where it intersects with political considerations. And what is going on in Washington, D.C., now is Exhibit A. And the solution to all of this tumult is in our collective hands as long as we are able to have free elections. Irving Kent Loh, M.D., is a preventive cardiologist and the director of the Ventura Heart Institute in Thousand Oaks. Email him at drloh@ This article originally appeared on Ventura County Star: Dr. Loh: In the crosshairs — American healthcare leadership
